Arbutus Biopharma Stock Options

ABUS Stock  USD 3.27  0.15  4.39%   
Arbutus Biopharma's latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.81. The Arbutus Biopharma option chain provides detailed quote and price information for the current Arbutus Biopharma Corp option contracts. It shows all of Arbutus Biopharma's listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on Arbutus Biopharma

Analyzing Arbutus Biopharma's in-the-money options over time can help investors to take a profitable long position in Arbutus Biopharma regardless of its overall volatility. This is especially true when Arbutus Biopharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Arbutus Biopharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Arbutus Biopharma's stock while costing only a fraction of its price.

Arbutus Current Options Market Mood

Arbutus Biopharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Arbutus Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Most options investors, including buyers and sellers of Arbutus Biopharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Arbutus Biopharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Arbutus contract

Base on the Rule 16, the options market is currently suggesting that Arbutus Biopharma Corp will have an average daily up or down price movement of about 0.0506% per day over the life of the 2025-01-17 option contract. With Arbutus Biopharma trading at USD 3.27, that is roughly USD 0.001655. If you think that the market is fully incorporating Arbutus Biopharma's daily price movement you should consider buying Arbutus Biopharma Corp options at the current volatility level of 0.81%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Arbutus Biopharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Arbutus calls. Remember, the seller must deliver Arbutus Biopharma Corp stock to the call owner when a call is exercised.

Arbutus Biopharma Option Chain

When Arbutus Biopharma's strike price is surpassing the current stock price, the option contract against Arbutus Biopharma Corp stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Arbutus Biopharma's option chain is a display of a range of information that helps investors for ways to trade options on Arbutus. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Arbutus. It also shows strike prices and maturity days for a Arbutus Biopharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
ABUS250117C0000100001.00.0 - 5.05.0Out
Call
ABUS250117C0000050000.50.3 - 5.00.3Out
Call
ABUS250117C0000200002.00.0 - 4.54.5Out
Call
ABUS250117C0000150001.50.1 - 2.950.1Out
Call
ABUS250117C0000300003.00.0 - 4.14.1Out
Call
ABUS250117C0000250002.50.3 - 4.00.3Out
Call
ABUS250117C0000400004.00.0 - 4.04.0Out
Call
ABUS250117C0000350003.50.25 - 0.40.25Out
Call
ABUS250117C0000500005.00.0 - 3.93.9Out
Call
ABUS250117C0000700007.00.0 - 3.83.8Out
 Put
ABUS250117P0000100001.00.0 - 0.40.4Out
 Put
ABUS250117P0000050000.50.0 - 0.750.75Out
 Put
ABUS250117P0000200002.00.05 - 2.40.05Out
 Put
ABUS250117P0000150001.50.0 - 0.150.15Out
 Put
ABUS250117P0000300003.00.8 - 2.00.8Out
 Put
ABUS250117P0000250002.50.3 - 0.450.3Out
 Put
ABUS250117P0000400004.01.3 - 2.751.3Out
 Put
ABUS250117P0000350003.50.95 - 1.20.95Out
 Put
ABUS250117P0000500005.02.2 - 3.22.2Out
 Put
ABUS250117P0000700007.02.6 - 6.92.6Out

Arbutus Biopharma Market Cap Over Time

   Market Cap   
       Timeline  

Arbutus Total Stockholder Equity

Total Stockholder Equity

93.47 Million

At this time, Arbutus Biopharma's Total Stockholder Equity is comparatively stable compared to the past year.

Arbutus Biopharma Corporate Management

Additional Tools for Arbutus Stock Analysis

When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.